Meng-Yu Liu , Sheng-Fu He , Yu-Yao Li , Jiao-Jiao Shen , Jia-Jia Li , Ya-Sheng Li , Yan-Yan Liu , Ting Wu , Jia-Bin Li , Li-Fen Hu
{"title":"Alterations in the intestinal fungal microbiome of patients with severe fever with thrombocytopenia syndrome","authors":"Meng-Yu Liu , Sheng-Fu He , Yu-Yao Li , Jiao-Jiao Shen , Jia-Jia Li , Ya-Sheng Li , Yan-Yan Liu , Ting Wu , Jia-Bin Li , Li-Fen Hu","doi":"10.1016/j.jiph.2025.102837","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div><em>Aspergillus</em> coinfection in patients with severe fever with thrombocytopenia syndrome (SFTS), is a serious clinical challenge associated with increased mortality. Understanding the factors contributing to this co-infection is crucial for improving patient outcomes. This study aimed to reveal the role of the intestinal mycobiome in SFTS severity and the risk of <em>Aspergillus</em> coinfection, with the goal of identifying potential therapeutic targets.</div></div><div><h3>Methods</h3><div>Fecal samples were collected from 80 patients both during their hospitalization and post-discharge. Internal transcribed spacer (ITS) amplicon sequencing and fungal profiling of intestine were performed. R statistical software (version 3.5.1) was used for data processing and analysis.</div></div><div><h3>Results</h3><div>The intestinal mycobiomes of SFTS patients showed strong alterations characterized by increased <em>Aspergillus</em> species, and a highly heterogeneous mycobiome configuration compared to healthy controls. The <em>Aspergillus</em> had a positive correlation with coinfection of invasive pulmonary aspergillosis (IPA) and disease severity of SFTS (<em>p</em> < 0.001), whereas <em>Saccharomycetales</em> and <em>Candida</em> were more abundant in SFTS patients without IPA (<em>p</em> < 0.001). In SFTS patients with IPA, <em>A. subversicolor</em>, <em>A. flavus</em> and <em>A. penicillioides</em> were the three most common fungal species. Longitudinal dynamic detection revealed that patients who experienced significant fluctuations in their intestinal mycobiome tended to have more severe illness. After recovering, the gut mycobiome of patients can recover and stabilize within a month.</div></div><div><h3>Conclusion</h3><div>The research highlighted enrichment of intestinal <em>Aspergillus</em> was conducive to IPA and disease severity in SFTS patients. Monitoring the gut mycobiome could potentially be used as a biomarker to assess disease severity of SFTS.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"18 9","pages":"Article 102837"},"PeriodicalIF":4.7000,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Public Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1876034125001868","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Aspergillus coinfection in patients with severe fever with thrombocytopenia syndrome (SFTS), is a serious clinical challenge associated with increased mortality. Understanding the factors contributing to this co-infection is crucial for improving patient outcomes. This study aimed to reveal the role of the intestinal mycobiome in SFTS severity and the risk of Aspergillus coinfection, with the goal of identifying potential therapeutic targets.
Methods
Fecal samples were collected from 80 patients both during their hospitalization and post-discharge. Internal transcribed spacer (ITS) amplicon sequencing and fungal profiling of intestine were performed. R statistical software (version 3.5.1) was used for data processing and analysis.
Results
The intestinal mycobiomes of SFTS patients showed strong alterations characterized by increased Aspergillus species, and a highly heterogeneous mycobiome configuration compared to healthy controls. The Aspergillus had a positive correlation with coinfection of invasive pulmonary aspergillosis (IPA) and disease severity of SFTS (p < 0.001), whereas Saccharomycetales and Candida were more abundant in SFTS patients without IPA (p < 0.001). In SFTS patients with IPA, A. subversicolor, A. flavus and A. penicillioides were the three most common fungal species. Longitudinal dynamic detection revealed that patients who experienced significant fluctuations in their intestinal mycobiome tended to have more severe illness. After recovering, the gut mycobiome of patients can recover and stabilize within a month.
Conclusion
The research highlighted enrichment of intestinal Aspergillus was conducive to IPA and disease severity in SFTS patients. Monitoring the gut mycobiome could potentially be used as a biomarker to assess disease severity of SFTS.
期刊介绍:
The Journal of Infection and Public Health, first official journal of the Saudi Arabian Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and the Saudi Association for Public Health, aims to be the foremost scientific, peer-reviewed journal encompassing infection prevention and control, microbiology, infectious diseases, public health and the application of healthcare epidemiology to the evaluation of health outcomes. The point of view of the journal is that infection and public health are closely intertwined and that advances in one area will have positive consequences on the other.
The journal will be useful to all health professionals who are partners in the management of patients with communicable diseases, keeping them up to date. The journal is proud to have an international and diverse editorial board that will assist and facilitate the publication of articles that reflect a global view on infection control and public health, as well as emphasizing our focus on supporting the needs of public health practitioners.
It is our aim to improve healthcare by reducing risk of infection and related adverse outcomes by critical review, selection, and dissemination of new and relevant information in the field of infection control, public health and infectious diseases in all healthcare settings and the community.